Location History:
- Potomac, MD (US) (2018)
- Libertyville, IL (US) (2014 - 2022)
- Potomoc, MD (US) (2022)
Company Filing History:
6 out of 822 
1 out of 167 
Years Active: 2014-2022
Title: The Innovative Contributions of Inventor Ping Tong in Pharmaceutical Advancements
Introduction: Ping Tong, an accomplished inventor based in Libertyville, IL, has made significant strides in the field of pharmaceuticals, contributing his expertise to the development of innovative treatments. With a portfolio that includes six patents, Tong's work focuses on creating solid dispersions that enhance drug delivery and efficacy.
Latest Patents: Among his notable inventions, two recent patents stand out. The first, titled "Melt-extruded solid dispersions containing an apoptosis-inducing agent," presents a pro-apoptotic solid dispersion consisting of a Bcl-2 family protein inhibitory compound in a non-crystalline form. This composition is designed to be orally administered for treating diseases characterized by an overexpression of anti-apoptotic Bcl-2 family proteins, such as cancer or autoimmune diseases. The preparation process involves creating an extrudable semi-solid mixture from the compound, a water-soluble polymeric carrier, and a surfactant, which is then extruded and cooled to form the solid matrix.
The second patent, "Solid pharmaceutical compositions for treating HCV," details compositions that contain two key compounds, with specific formulations for each layer aimed at enhancing drug solubility and absorption. This innovative approach utilizes amorphous solid dispersions to improve the pharmacological properties of the medications.
Career Highlights: Throughout his career, Ping Tong has worked with reputable organizations in the pharmaceutical industry, including AbbVie Inc. and AbbVie Deutschland GmbH & Co. KG. His tenure at these companies has allowed him to collaborate with some of the brightest minds in the field, refining his skills in drug formulation and development.
Collaborations: Tong has had the opportunity to work alongside notable colleagues such as Nathaniel Catron and Eric Allen Schmitt. These collaborations have undoubtedly enriched his research experience and fostered innovation within pharmaceutical development.
Conclusion: Ping Tong's inventive contributions in the realm of pharmaceuticals illustrate his dedication to advancing medical science. His patents reflect a commitment to addressing critical health challenges, particularly in the treatment of cancer and viral infections. With a track record of innovation, Tong continues to be a prominent figure in the landscape of pharmaceutical research.